Andreas L. Hoel

Andreas L. Hoel has a diverse work experience spanning over several companies and roles. Andreas is currently the Vice President of Marketing and Sales at A3P Biomedical since November 2022. In addition, they serve as a Board Member at Axlab, a privately owned anatomic pathology and cancer diagnostics company, focusing on strategic growth and market penetration for innovative cancer diagnostic solutions since August 2022.

From 2016 to 2022, Andreas held senior leadership positions at Thermo Fisher Scientific. Andreas was the Sr. Director of Customer Experience in the Microbiology Division from September 2019 to November 2022. Prior to that, they served as the Sr. Director of Marketing in the Clinical Diagnostics Division from November 2016.

Before joining Thermo Fisher Scientific, Andreas worked at Agilent Technologies as the Sr. Director of Portfolio Management, Pathology from January 2016 to October 2016. Their responsibilities included managing the marketing and project management functions in the cancer diagnostics division, aligning customer needs with product development projects.

Andreas has also contributed to the success of Dako, where they held several roles. Andreas was the Global Marketing Director for IHC from April 2014 to January 2016. In addition, they served as the Director of the Global Commercialization Team, leading the global launch of a major new diagnostic solution in the cancer diagnostics arena from November 2012 to April 2014. Prior to that, they served as Sr. Global Marketing Manager, Global Marketing Manager, and Global Product Manager from 2011 to 2012 and from 2007 to 2010, respectively.

Early in their career, Andreas worked as a Product Manager at Biotage from November 2005 to March 2007. Andreas also held the role of Regional Sales Manager for Central Europe at Biotage AB from 2004 to 2005.

Andreas began their career at Personal Chemistry, where they worked as an International Sales Manager from 2002 to 2004 and as a Chemistry Support Manager from 2000 to 2002.

Overall, Andreas L. Hoel possesses extensive experience in leadership, marketing, and sales roles within the biomedical, pathology, and cancer diagnostics industries.

Andreas L. Hoel began their education in 1989 at Niels Steensen Gymnasium. After completing their high school education, they went on to attend the Technical University of Denmark (DTU) from 1992 to 1998, where they obtained a Master of Science (M.Sc.) degree in Organic Chemistry.

In 1995, Andreas briefly attended the Norwegian University of Science and Technology (NTNU), focusing on Chemistry. Andreas then pursued a thesis project in chemistry at Stanford University in 1998. Although the duration is not specified, it can be assumed that their time at Stanford was relatively short.

Following their studies in chemistry, Andreas pursued a Master of Business Administration (MBA) in General Management from Henley Business School, completing their degree from 2003 to 2006.